COMMUNIQUÉS West-GlobeNewswire

Resalis Therapeutics Appoints Diana M. Røpcke as Chief Medical Officer
02/09/2026
Dr. Røpcke joins Resalis with extensive experience in clinical drug development as well as expertise in obesity and cardiometabolic therapy areas Torino, Italy, September 2, 2026 – Resalis Therapeutics , a biotechnology [...]
CDT Provides Capital Update and Confirms No Nasdaq Deficiencies
02/09/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept. 02, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“ CDT ” or the “ Company ”) today announced that, following the recent issuance of shares and the exercise of [...]
DoKegel Launches Personalized Pelvic Floor Training App for Men
02/09/2026
New DoKegel App Turns a Short Quiz Into a Daily Kegel Routine NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- DoKegel has launched a men's wellness app built around personalized Kegel exercises. The app pairs guided pelvic [...]
NewBiologix and Synastra Biotechnology Partner to Advance Stable rAAV Manufacturing for Duchenne Muscular Dystrophy Gene Therapy
02/09/2026
Collaboration will use NewBiologix’s Xcell™ platform to establish a scalable manufacturing foundation for Synastra’s investigational DMD gene therapy program LAUSANNE, Switzerland, Sept. 02, 2026 (GLOBE NEWSWIRE) -- [...]
Levicept Announces Attendance at Cantor and Jefferies Global Healthcare Conferences
02/09/2026
SANDWICH, United Kingdom, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Levicept Ltd, a biotechnology company focused on the development of LEVI-04, a first-in-class clinical-stage treatment for osteoarthritis (OA), today [...]
Novonesis to build next generation enzyme production facility in India
02/09/2026
Novonesis will invest €600 million to expand its site in  Patalganga  and build a state-of-the-art facility. This marks another step in the company's long-term growth strategy and continued investment in its global [...]
Nicox Announces Extension of Cash Runway
02/09/2026
Press Release Nicox Announces Extension of Cash Runway Cash position, of €8.4 million 1 as of 31 August 2026, sufficient to fund existing operations beyond Q1 2028 NCX 470 U.S. NDA approval milestone would fund [...]
Nicox annonce l’extension de son horizon de trésorerie
02/09/2026
Communiqué de presse Nicox annonce l’extension de son horizon de trésorerie Position de trésorerie de 8.4 millions d’euros 1 au 31 août 2026 , suffisante pour financer les opérations actuelles au-delà du 1er trimestre [...]
IBA joins PFAROS European initiative to advance PFAS destruction for healthcare and pharmaceutical applications
02/09/2026
Louvain-la-Neuve, Belgium, 2 September 2026, 7 a.m. – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today announces its participation in PFAROS, a new European research [...]
IBA rejoint l’initiative européenne PFAROS pour accélérer le développement de solutions de destruction des PFAS dans les secteurs de la santé et de la pharmacie
02/09/2026
Louvain ‑ la ‑ Neuve, Belgique, le 2 septembre 2026, 7h00 – IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial des technologies d’accélérateurs de particules, annonce aujourd’hui sa participation à PFAROS, [...]
Desert Hope Treatment Center Addresses Community Need for Increased Addiction Services with New Virtual Program
02/09/2026
LAS VEGAS, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Desert Hope Treatment Center, a leading addiction treatment provider in Las Vegas, has added a virtual intensive outpatient treatment program to its array of care services. [...]
Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway
02/09/2026
The Phase 3 BiPASS™ study of Illuccix® and Gozellix® for prostate cancer imaging in the pre-biopsy setting has completed enrollment of 350 patients. Telix has positively engaged with the FDA on a New Drug Application ( [...]
Pennant Group to Participate in the 2026 Jefferies Healthcare Services Conference
02/09/2026
EAGLE, Idaho, Sept. 01, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it [...]
HWH International Inc. Announces Executive Leadership Transition
01/09/2026
BETHESDA, MD, Sept. 01, 2026 (GLOBE NEWSWIRE) -- HWH International Inc. (Nasdaq: HWH) ("HWH" or the "Company") today announced a transition in its executive leadership. Chan Heng Fai (“ Mr. Chan ”), the Company's [...]
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/09/2026
SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib [...]
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September
01/09/2026
CAMBRIDGE, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients [...]
aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis
01/09/2026
Company anticipates response from FDA by mid-September 2026 on protocol submitted for planned Phase 3 study of efzofitimod in patients with pulmonary sarcoidosis with restrictive lung disease. SAN DIEGO, Sept. 01, 2026 [...]
STERIS to Present at the Morgan Stanley Healthcare Conference
01/09/2026
Dublin, Ireland, Sept. 01, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will participate in the Morgan Stanley Healthcare Conference in New York City on Tuesday, [...]
Cellectis Announces Participation in Upcoming Investor Conferences
01/09/2026
NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving [...]

Pages